| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.347 | 30.135 | - | 44.809 | 30.030 | - | - | 17.238 | 9.126 | 0 |
| Total Income - EUR | 36.089 | 30.155 | - | 45.020 | 30.114 | - | - | 17.308 | 9.126 | 985 |
| Total Expenses - EUR | 1.899 | 4.951 | - | 26.224 | 28.933 | - | - | 11.940 | 6.162 | 1.525 |
| Gross Profit/Loss - EUR | 34.190 | 25.204 | - | 18.796 | 1.181 | - | - | 5.369 | 2.964 | -540 |
| Net Profit/Loss - EUR | 33.107 | 24.299 | - | 17.452 | 280 | - | - | 4.852 | 2.490 | -540 |
| Employees | 2 | 2 | - | 1 | 1 | - | - | 0 | 0 | 0 |
Check the financial reports for the company - Anamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.283 | 1.810 | - | 6.086 | 18.260 | - | - | 1.155 | 903 | 724 |
| Current Assets | 3.530 | 17.938 | - | 39.248 | 26.505 | - | - | 40.997 | 43.994 | 42.832 |
| Inventories | 0 | 0 | - | 0 | 0 | - | - | 0 | 0 | 0 |
| Receivables | 0 | 17.027 | - | 27.998 | 19.675 | - | - | 18.384 | 18.329 | 18.226 |
| Cash | 3.530 | 910 | - | 11.250 | 6.830 | - | - | 22.613 | 25.665 | 24.606 |
| Shareholders Funds | -4.991 | 19.359 | - | 44.464 | 43.883 | - | - | 41.826 | 44.189 | 43.402 |
| Social Capital | 45 | 45 | - | 43 | 42 | - | - | 41 | 40 | 40 |
| Debts | 10.804 | 389 | - | 870 | 882 | - | - | 326 | 708 | 154 |
| Income in Advance | 0 | 0 | - | 0 | 0 | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Anamed S.r.l.